Clinical trials for Cancer in United States

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

Study ID: NCT06879340

Sponsor

University of Kansas Medical Center

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

Study ID: NCT05423210

Sponsor

Stony Brook University

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

Study ID: NCT07033026

Sponsor

NGM Biopharmaceuticals, Inc

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Study ID: NCT06398418

Sponsor

Rise Therapeutics LLC

Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse

Study ID: NCT06827860

Sponsor

Larysa Sanchez

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Study ID: NCT06745882

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

Study ID: NCT06112990

Sponsor

University of Utah

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

Study ID: NCT05794958

Sponsor

Stanford University

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

Study ID: NCT06370143

Sponsor

Memorial Sloan Kettering Cancer Center

United Against HPV

Study ID: NCT06825689

Sponsor

University of Texas at Austin